P2 Capital Partners’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.62M Hold
320,000
2.7% 11
2026
Q1
$7.28M Sell
320,000
-275,000
-46% -$6.5M 3.47% 10
2025
Q4
$15.9M Hold
595,000
4.06% 10
2025
Q3
$18.1M Sell
595,000
-22,149
-4% -$672K 3.47% 13
2025
Q2
$19.4M Buy
617,149
+287,149
+87% +$9.5M 3.7% 13
2025
Q1
$12.6M Hold
330,000
2.45% 11
2024
Q4
$14.5M Sell
330,000
-130,000
-28% -$5.71M 2.46% 11
2024
Q3
$19.8M Hold
460,000
2.26% 13
2024
Q2
$20.8M Buy
+460,000
New +$23.9M 2.28% 15

Other funds holding ENOV

P2 Capital Partners's ENOV Position: Q2 2026 in Review

P2 Capital Partners held its Enovis (ENOV) position steady in Q2 2026 at 320,000 shares worth $6.62M. The position accounts for 2.7% of the portfolio, ranked #11.

P2 Capital Partners first reported a position in ENOV in Q2 2024 and has held it in 9 quarters since. The position peaked at $20.8M in Q2 2024. 253 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • P2 Capital Partners held 320,000 shares of Enovis worth $6.62M as of Q2 2026.
  • P2 Capital Partners left its Enovis share count unchanged in Q2 2026.
  • Enovis made up 2.7% of P2 Capital Partners's portfolio in Q2 2026, its #11 holding.
  • P2 Capital Partners first reported a position in Enovis in Q2 2024 and has held it in 9 quarters since.
  • P2 Capital Partners's Enovis position peaked at $20.8M in Q2 2024.
  • 253 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on P2 Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.